Latest close: below its 200-day averageSep 8, 2026what changed →2024-08-14$82.56 – $136.78 · dashed line: 200-day average2026-09-08
What is the market doing?
What the tape says about ABT
Abbott Laboratories is −19% over the past year while the S&P 500 is +20%: 39 points behind the market. Through the fall, its own insiders bought $3.9M more stock than they sold.
−19%
1-year return · S&P 500 +20%
- vs 200-day average
- −1.9%
vs 200-day average · below trend, but not far
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 22%
Below its 52-week high
Details›
- Last close2026-09-08
- $105.58
- 1 monthS&P 500 −0.30%
- −2.2%
- 1 yearS&P 500 +20%
- −19%
- 5 yearsS&P 500 +85%
- −5.8%
- vs 50-day average$102.43
- +3.1%
- 52-week high
- $134.49
- 52-week low
- $82.56
- Annualised volatility
- 24%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $3.9M
| Year | Return |
|---|---|
| 2026 (year to date) | −15% |
| 2025 | +13% |
| 2024 | +4.8% |
| 2023 | +2.3% |
| 2022 | −21% |
| 2021 | +31% |
| 2020 | +28% |
| 2019 | +22% |
| 2018 | +29% |
| 2017 | +52% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 8 of 10 | +3.1% |
| Feb | 10 | 5 of 10 | +0.25% |
| Mar | 10 | 3 of 10 | −1.9% |
| Apr | 10 | 3 of 10 | +0.17% |
| May | 10 | 5 of 10 | −0.49% |
| Jun | 10 | 6 of 10 | +2.0% |
| Jul | 11 | 10 of 11 | +5.5% |
| Aug | 11 | 7 of 11 | +1.1% |
| Sep | 11 | 5 of 11 | −0.77% |
| Oct | 10 | 4 of 10 | −0.99% |
| Nov | 10 | 8 of 10 | +3.9% |
| Dec | 10 | 7 of 10 | +1.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Devices
The closest names by size in the same industry